Drug intelligence / Profile preview

G-CSF + dexamethasone

Development stage
Unknown
Lead developer
Amgen
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intravenous, Oral
01

Overview

G-CSF + dexamethasone is a combination regimen consisting of granulocyte colony-stimulating factor (G-CSF) and the corticosteroid dexamethasone. This combination is primarily used to mobilize neutrophils (polymorphonuclear leukocytes, PMNs) in healthy donors for granulocyte transfusion programs or to increase neutrophil counts in clinical settings where rapid neutrophil mobilization is required. G-CSF acts as a hematopoietic growth factor that stimulates the bone marrow to produce and release neutrophils into the bloodstream, while dexamethasone enhances this effect through its anti-inflammatory and immunomodulatory properties. The combined administration has been shown to result in significantly higher peripheral blood neutrophil counts than either agent alone[1][6]. This regimen is well-tolerated and effective for optimal PMN mobilization.

Other names
G-CSF + dexamethasoneG-CSF and dexamethasonegranulocyte colony-stimulating factor + dexamethasone
02

Targets

CSF3R (Granulocyte colony-stimulating factor receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on G-CSF + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G-CSF + dexamethasone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call